Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Nagashima

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|May 14, 2013
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatmentTakayuki Inoue, Masataka Morita, Takashi Tojo, et al.
Chest|July 13, 2002
Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapyMasakazu Sugaya, Mitsuhiro Takenoyama, Toshihiro Osaki, et al.
Bioorganic & Medicinal Chemistry|October 10, 2017
Synthesis and structure activity relationships of carbamimidoylcarbamate derivatives as novel vascular adhesion protein-1 inhibitorsSusumu Yamaki, Hiroyoshi Yamada, Akira Nagashima, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 3, 2019
[A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin]Atsushi Ohgushi, Natsumi Nakayama, Atsuo Namiki, et al.
Bioorganic & Medicinal Chemistry|April 2, 2013
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2Takayuki Inoue, Masataka Morita, Takashi Tojo, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2020
Renoprotective Effects of a Novel Receptor-Interacting Protein Kinase 2 Inhibitor, AS3334034, in Uninephrectomized Adriamycin-Induced Chronic Kidney Disease RatsYusuke Wada, Mitsuhiro Kondo, Kumi Sakairi, et al.
Bioorganic & Medicinal Chemistry|June 12, 2017
Synthesis and pharmacological evaluation of glycine amide derivatives as novel vascular adhesion protein-1 inhibitors without CYP3A4 and CYP2C19 inhibitionSusumu Yamaki, Yuji Koga, Akira Nagashima, et al.
In Vivo (Athens, Greece)|December 29, 2019
Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung AdenocarcinomaTakaaki Nakashima, Takeshi Nonoshita, Hidenari Hirata, et al.
Bioorganic & Medicinal Chemistry|January 23, 2013
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edemaTakayuki Inoue, Masataka Morita, Takashi Tojo, et al.
Anticancer Research|August 5, 2010
Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancerMasakazu Sugaya, Hidetaka Uramoto, Akihiko Uchiyama, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|May 14, 2013
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatmentTakayuki Inoue, Masataka Morita, Takashi Tojo, et al.
Chest|July 13, 2002
Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapyMasakazu Sugaya, Mitsuhiro Takenoyama, Toshihiro Osaki, et al.
Bioorganic & Medicinal Chemistry|October 10, 2017
Synthesis and structure activity relationships of carbamimidoylcarbamate derivatives as novel vascular adhesion protein-1 inhibitorsSusumu Yamaki, Hiroyoshi Yamada, Akira Nagashima, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 3, 2019
[A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin]Atsushi Ohgushi, Natsumi Nakayama, Atsuo Namiki, et al.
Bioorganic & Medicinal Chemistry|April 2, 2013
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2Takayuki Inoue, Masataka Morita, Takashi Tojo, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 21, 2020
Renoprotective Effects of a Novel Receptor-Interacting Protein Kinase 2 Inhibitor, AS3334034, in Uninephrectomized Adriamycin-Induced Chronic Kidney Disease RatsYusuke Wada, Mitsuhiro Kondo, Kumi Sakairi, et al.
Bioorganic & Medicinal Chemistry|June 12, 2017
Synthesis and pharmacological evaluation of glycine amide derivatives as novel vascular adhesion protein-1 inhibitors without CYP3A4 and CYP2C19 inhibitionSusumu Yamaki, Yuji Koga, Akira Nagashima, et al.
In Vivo (Athens, Greece)|December 29, 2019
Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung AdenocarcinomaTakaaki Nakashima, Takeshi Nonoshita, Hidenari Hirata, et al.
Bioorganic & Medicinal Chemistry|January 23, 2013
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edemaTakayuki Inoue, Masataka Morita, Takashi Tojo, et al.
Anticancer Research|August 5, 2010
Phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel in patients with completely resected non-small cell lung cancerMasakazu Sugaya, Hidetaka Uramoto, Akihiko Uchiyama, et al.
Pageof 4